Severo Ochoa Programme 2018-2022 Health NEWS

Monday, 27 April 2020

Prof. Kostas Kostarelos claims scientists should be back in the labs as ‘essentials’ to face COVID-19 emergency

In an opinion article published today by Nature Nanotechnology, Prof. Kostas Kostarelos shares his views on what may be going wrong in the fight against COVID-19 and how the nanoscience community could contribute. He suggests applying the three key principles in managing an individual cancer patient: early detection, monitoring and targeting. Prof. Kostas Kostarelos recently became Senior Group Leader at the ICN2 after a long-standing collaboration that is now reinforced through the ICN2 Severo Ochoa talent attraction strategy. He will continue directing the Nanomedicine Lab at the University of Manchester, while also leading the new ICN2 Nanomedicine Group.

Monday, 06 April 2020

Prof. Laura Lechuga explains the CoNVaT project on RTVE

In the edition of 4 April of the “Informe Semanal”, weekly in-depth news show of the RTVE, Prof. Laura Lechuga presented CoNVaT, the European funded project that she leads, which aims at the development of a fast, cheap and handy test device for the diagnosis of the COVID-19.

Thursday, 02 April 2020

La Vanguardia highlights the diagnostic tests by Paperdrop Dx

Paperdrop Diagnostics is the ICN2 and ICREA spin-off devoted to the development of rapid diagnostic tests based on paper microfluidics. La Vanguardia remarks their new test for ischemic stroke, based on the evaluation of microRNA, and their efforts to produce a Covid-19 test from this technology.

Wednesday, 01 April 2020

CoNVaT will design a new diagnostic system for COVID-19 with the best current technologies

The ICN2 Nanobiosensors and Bioanalytical Applications Group, led by Prof. Laura Lechuga, coordinates a European project with a budget over 2 million euros. They have become an international reference in COVID-19 diagnostics and have prepared a report for the Ministry of Science and Innovation analysing the characteristics, advantages and limitations of current detection systems for diagnosing COVID-19.

Tuesday, 17 March 2020

The ICN2 minimises its activity due to the State of Alarm

Since last week the ICN2 has adapted its activity level to the quickly evolving context caused by the COVID-19 disease spread. As per today, only very few ICN2 members are allowed to enter the ICN2 facilities, including the research Group led by Prof. Laura Lechuga who is leading the CONVAT project to design a tool to diagnose COVID-19. Most of the personnel will remain active working, contributing to fight this spreading disease by following the indications published by authorities as well as through research.

Friday, 06 March 2020

The ICN2 leads a European project to diagnose the COVID-19 disease in 30 minutes

The CONVAT project, led and coordinated by Prof. Laura M. Lechuga, CSIC Research Professor at the Catalan Institute of Nanoscience and Nanotechnology (ICN2), will develop a point-of-care platform for rapid diagnosis and monitoring of coronavirus. The biosensor device will also allow the analysis of different types of coronavirus present in reservoir animals, such as bats, to monitor the evolution of these viruses and prevent future infectious outbreaks in humans.

Tuesday, 11 February 2020

DOC-FAM doctoral students celebrate a welcome event

ICMAB coordinates CSIC’s DOC-FAM excellence DOCtoral training programme in Functional Advanced Materials, which is providing excellent doctoral students to collaborator institutions such as the ICN2. The predoctoral students hired in the second call of this H2020-MSCA-COFUND action offered a short presentation about their research and personal objectives. Two of them, Alejandro Astúa and Alejandro Astúa work at the ICN2 and were supported by their group leaders, Prof. Laura Lechuga and Prof. Pedro Gómez, respectively.

Monday, 10 February 2020

Cerium oxide nanoparticles may improve hepatocellular carcinoma prognosis

This liver cancer is the most common and is in need of new therapeutic approaches. A long-term collaboration between IDIBAPS and ICN2, led by Prof. Wladimiro Jiménez and Prof. ICREA Víctor F. Puntes, has demonstrated that the administration of cerium oxide nanoparticles in a rat animal model can compete with the best currently available treatments. The Research published in Hepatology shows that human tissues also absorb and retain the nanoparticles, making them a potential and promising new drug strategy.

Tuesday, 04 February 2020

Vote for our brain graphene-based devices!

La Vanguardia has selected the brain-computer interfaces designed by the ICN2 and IMB-CNM-CSIC, with a long list of close collaborators, among the candidates to win its prestigious award Vanguardia de la Ciencia. Help us disseminate the fight against epilepsy, migraine or brain damage with nanotechnology. The winner will be one of the 8 candidates that will be selected through popular vote.

Tuesday, 28 January 2020

The ICN2 will shine at Nanotech Japan

Together with CERCA and CSIC the ICN2 will have a central role at the Spanish Pavilion of the Nanotech 2020 starting tomorrow. With over 350 exhibitors, this event is a huge meeting point for industry and academic institutions. The event is sided by the 1&2D materials congress, starting today, a Japan-Albania-Spain workshop, to be held tomorrow and organized by ICREA Prof. Arben Merkoçi and Phantoms Foundation, and a visit to RIKEN headquarters.

Tuesday, 17 December 2019

CERCA Pioneer Awards 2019

Two former ICN2 PhD students, Dr Bhawna Nagar and Dr Núria Fabri Faja, have been granted the CERCA Pioneer Award 2019 for their doctoral theses. The prize is a recognition for research works that stand out for their industrial- and commercial-oriented perspective.

Tuesday, 19 November 2019

Severo Ochoa 2.0: New Directions and Opportunities

On November 15, a special event was organized to present to the whole ICN2 community the new directions and opportunities provided by the second Severo Ochoa Programme. The event was organized by the ICN2 Management and the Strategy Development Office, together with the Severo Ochoa Programme Committee.

Monday, 28 October 2019

An ICN2 graphene-based screening device is being showcased at the Graphene Marketplace hosted by Tetra Pak

Dr Ruslan Álvarez, from the ICN2 Nanobioelectronics and Biosensors Group, and Dr Cinzia Spinato, from the ICN2 Business and Innovation Office, are participating in the Marketplace being held at Modena by Tetra Pak and the Graphene Flagship. They are presenting an intuitive, eco-friendly, portable sensing system to screen for different compounds found in food and environmental samples.

Tuesday, 17 September 2019

i-Vision and InBrain projects hit the news after being granted by “la Caixa”

ICREA Prof. Jose Antonio Garrido, head of the ICN2 Advanced Electronic Materials and Devices Group, and Damià Viana, PhD student of the same Group, received a “la Caixa” Health Research Grant and a CaixaImpulse Grant, respectively. Both initiatives seek to develop new graphene-based neural interfaces for clinical applications and received broad media coverage in the context of the awards ceremony celebrated yesterday.

Monday, 16 September 2019

CaixaImpulse awards an ICN2 project on engineered graphene for neural interfaces

The selected InBrain Technologies project is led by Damià Viana, PhD student from the ICN2 Advanced Electronic Materials and Devices Group. CaixaImpulse is an acceleration programme that helps early stage biomedical research projects to validate their asset and define their valorisation plan. The programme aims to facilitate the leap from basic research to the market.

Monday, 16 September 2019

The graphene-based retinal implants to restore vision awarded a “la Caixa” Health Research Grant

“La Caixa” Foundation has announced today the winners of the second edition of “la Caixa” Health Research Grants. IFAE, ICFO, Barraquer Foundation and Institut de la Vision (University of Sorbonne) are the partner institutions forming the i-VISION research consortium led by the ICN2 and awarded with 1 million euros. The three-year project will design the next generation of retinal prostheses using graphene-based electrodes to provide artificial vision to patients blinded by retinal degeneration.

Monday, 18 March 2019

Gold nanoparticles to facilitate in-situ detection of amplified DNA at room temperature

The proposed nanobiosensor developed by ICN2 Nanobioelectronics and Biosensors Group led by ICREA Prof. Arben Merkoçi and Vetgenomics takes advantage of the high sensitivity achieved when using gold nanoparticles in the sensing surface. The sensor integrates DNA amplification and detection, which is of high interest for human, veterinarian and plant diagnostics. The results have been published in Analytical Chemistry.